High-resolution structural information only covers 15% of full-length sequence of RyR. Results: Pseudo-atomic structures are generated for RyR1 fragment 850-1,056 and RyR2 861-1,067, docked into cryo-EM maps, and supported by FRET experiments.
SUMMARY
Ryanodine receptors (RyRs) form a class of intracellular calcium release channels in various excitable tissues and cells such as muscles and neurons. They are the major cellular mediators of the release of calcium ions from the sarcoplasmic reticulum, an essential step in muscle excitation-contraction coupling. Several crystal structures of skeletal muscle RyR1 peptide fragments have been solved, but these cover less than 15% of the full-length RyR1 sequence. In the present study, by combining modeling techniques with sub-nanometer resolution cryo-electron microscopy (cryo-EM) maps, we obtain pseudo-atomic models for RyR fragments consisting of residues 850-1,056 in rabbit RyR1 or residues 861-1,067 in mouse RyR2. These fragments are docked into a domain that connects the central vestibule and corner clamp region of RyR, resulting in a good match of the secondary structure elements in the cryo-EM map and the pseudo-atomic models, which is also consistent with our previous mappings of GFP insertions by cryo-EM and with FRET measurements involving RyR and FKBP. A combined model of the RyR fragment and FKBP docked into the cryo-EM map suggests that the fragment is positioned adjacent to the FKBP binding site. Its predicted binding interface with FKBP consists of primarily of electrostatic contacts and contains several disease-associated mutations. A dynamic interaction between the fragment and a RyR phosphorylation domain, characterized by FRET experiments, also supports the structural predictions of the pseudo-atomic models. ________________________________________ Ryanodine receptors (RyRs) are a class of intracellular calcium release channels existing in various excitable tissues and cells such as muscles and neurons. RyRs play an important role in regulating cytoplasmic calcium, which acts as a secondary messenger in cells. In striated muscle, RyRs release calcium from the sarcoplasmic reticulum in response to membrane depolarization. Mammalian RyRs exist in three isoforms: RyR1, RyR2 and RyR3, which distribute predominantly in skeletal muscle, cardiac muscle, and various tissues, respectively (1, 2) , and which share approximately 65% identity over their full-length sequences (3) .
All three isoforms of RyR have been cloned, and each primary sequence contains approximately 5,000 amino acids (3) (4) (5) . The Nterminal ~4,300 amino acids form a large cytoplasmic assembly that interacts with numerous intracellular modulators, and the Cterminal ~700 residues form a trans-membrane assembly that acts as an ion-conducting pore (6) . Functional RyR molecules are homo-tetramers of 2.3 MDa (565 kDa per monomer) making RyRs the largest ion channels known to date, and contributing to the difficulty in obtaining crystals suitable for atomic structure determination by Xray crystallography. In the past decades, several groups have determined three-dimensional (3D) reconstructions of intact RyRs at intermediate resolutions by cryo-electron microscopy (cryo-EM) (7) (8) (9) (10) (11) (12) . Recently, crystal structures of RyR1 fragments, mainly from the amino-terminal region, have been solved to atomic resolution (13) (14) (15) (16) . The largest fragment contains the first 559 residues, and covers approximately 11% of the entire RyR1 sequence (16) . It includes three separate domains, domain A (residues 1-205), domain B (206-394), and domain C (395-532). Docking the crystal structure of the ABC domains into a full-length RyR1 cryo-EM map has placed the domains in the cytoplasmic portion of RyR1, forming a central rim in the cytoplasmic assembly (16) . More recently, crystal structures of a phosphorylation domain in RyR1 (residues 2,733/2734-2,940), and its corresponding domains in RyR2 (residues 2,699-2,904) and in RyR3 (residues 2,597-2,800) were reported by two independent research groups. These fragments were docked into a region near each corner of the cytoplasmic assembly (17, 18) . Nevertheless, further progress by this approach towards a high-resolution structure for RyR requires improvement in the cryo-EM resolution of structurally intact RyR, and determination of additional fragment crystal structures to fit into the cryo-EM maps.
RyRs are modulated by numerous natural and pharmacological ligands, and by covalent modifications such as phosphorylation, nitrosylation, and oxidation/reduction of cysteine sulfhydryl moieties (19) (20) (21) . Most of these bound ligands or modifications occur at specific sites on the cytoplasmic assembly, a fact that perhaps offers one explanation for the unusually large size of the cytoplasmic region. Cryo-EM has been utilized to determine the physical locations of some RyR protein binding partners, including calmodulin (22) (23) (24) , a 12-kDa or 12.6-kDa FK506-binding protein (FKBP12 or FKBP12.6) (22, 25, 26) , chloride intracellular channel 2 (27) , imperatoxin A from scorpion venom (28) , and natrin snake venom toxin (29) .
FKBP is a protein prolyl isomerase that is widely expressed and involved in many cell functions. Two isoforms, FKBP12 and FKBP12.6, bind tightly to RyR1 and RyR2, respectively, and may be considered as integral subunits of RyR (30, 31) . FKBP12 and FKBP12.6 share a high degree of sequence homology (85%), and it has been demonstrated by site-direct mutagenesis study that three residues specific to FKBP12.6 (Gln-31, Asn-32, and Phe-59) account for the selective binding to cardiac RyR2 (32) . On the other hand, sequences in RyR that participate in FKBP binding remain controversial. The valine2461-proline2462 motif in RyR1 (corresponding to isoleucine2427-proline2428 in RyR2) has been identified as being required for FKBP binding by site-direct mutagenesis (33) . However, the corresponding isoleucine2427-proline2428 motif in RyR2 is not required for FKBP12.6 binding for RyR2 (34) . Protein kinase A (PKA) phosphorylation of RyR2 dissociates FKBP12.6, and affects the RyR2 channel open probability, and phosphorylation of RyR2 at a single residue serine2808 (serine2843 in RyR1) activates the channel by releasing FKBP (35, 36) . However, this proposed mechanism is not consistent with other findings (37) (38) (39) (40) . In addition,
C-terminal truncation analysis demonstrated that a fragment between residues 1,815 and 1,855 in RyR2 is essential for GST-FKBP12.6 binding (41) . It is likely that more than one sequence in RyR participates in FKBP binding, as multiple sequences may form a binding pocket for FKBP when RyR folds and four subunits assemble into a homo-tetramer. In support of this hypothesis, we have mapped two residues, Tyr-846 and Thr-1874, that are widely separated in RyR2's primary sequence onto the 3D structure by cryo-EM, and we found that the structural domains bearing the two residues are both adjacent to the FKBP binding site (41, 42) .
In the present study, sequence homology was detected between the phosphorylation domain residues 2,733-2,940 in RyR1, for which a 2.2 Å crystal structure exists (18) , and residues 850-1,056 in rabbit RyR1 (henceforth called "RyR1 fragment") or residues 861-1,067 in mouse RyR2 (henceforth called "RyR2 fragment").
Pseudo-atomic models were generated for these fragments based on the available crystal structure, and these models were fitted into sub-nanometer resolution cryo-EM maps of RyR1 in both closed and open conformations using rigid-body docking and flexible fitting. The fragments docked optimally into a domain that connects the central vestibule and corner clamp region of RyR, which is consistent with our previous results from RyR-GFP mappings by 3D cryo-EM and from FRET measurement of RyR-FKBP interactions (42) . The docked location was further supported by detection of secondary structure features in the cryo-EM map, which matched the fitted models. The fragments were located adjacent to the FKBP binding site, and docking of an FKBP crystal structure revealed that a largely electrostatic type of interaction between the fragment and FKBP is likely. Several positions of disease-associated mutations were mapped into the modeled structure, and they are mainly located either in the binding interface with FKBP or near an interface that interacts with another RyR structural domain in the corner of the clamp region. We also designed a FRET pair to test for the existence of a dynamic interaction between the fragment in the modeled structure and a RyR phosphorylation domain. The FRET data demonstrate that these two structural domains belong to two neighboring RyR subunits, and they form an inter-subunit interaction that is sensitive to RyR channel activation. Taken together, these data suggest that the structural domain formed by the RyR1/RyR2 fragment play a role in mediating a dynamic domain-domain interaction within RyR, and in channel modulation by FKBP.
EXPERIMENTAL PROCEDURES
BLAST sequence analysis and comparative modeling. --To identify sequences in RyR whose structures could be modeled using structural templates from the PDB, we performed protein BLAST against PDB protein sequences for every 1200 residues with a small overlap of 200 residues for each alignment group. All five resulting sequence groups were aligned using the protein blast plug-in of UCSF Chimera (43) . A sequence portion of the third group (a.a. 2,001-3,200) matched the sequence of a RyR protein fragment (a.a. 2,733-2,940) whose crystal structure was known (PDB ID: 3RQR). In addition, residues 850-1,056 shared a high sequence homology with the 3RQR crystal structure sequence. The corresponding sequence in mouse RyR2 was identified by multiple sequence alignment using ClustalW2 (44) . Next, we chose the two isoforms as the target sequences with 3RQR chain A as the template to complete comparative modeling using the program MODELLER (45) . Five models were generated which differed to a slight degree mainly in the loop regions. We chose the model with the lowest estimated RMSD to perform the fitting in the next step. The differences between the modeling template and the homology model mainly exist in loop 3, helix 3, loop 4 and loop 5. We also submitted the sequences for the two isoforms to the I-TASSER server (46) , an on-line platform developed for protein structure predictions by an ab initio modeling protocol. Three models were generated for each isoform, and we chose the first model because of its highest C-score value, which is used for estimating the accuracy of the I-TASSER prediction (46) . When we superimposed models obtained from these two different modeling methods for individual isoforms by using Chimera, they were almost the same except for minor differences at the middle portion of loop 3, the C-terminal portion of helix 4 and loop 4, and there being no beta-sheets modeled in both two isoforms by I-TASSER (comparisons for each isoform are shown in Figure S1 and Figure  S2 ).
Rigid-body docking of template and simulated atomic models --Rigid-body docking was performed by using the FFT-accelerated 6D exhaustive search of the Situs package (47) . The modeling template 3RQR deposited in the PDB (rabbit RyR1 a.a. 2,733~2,940), two comparatively modeled structures of rabbit RyR1 fragment 850-1,056 and mouse RyR2 fragment 861-1,067 were docked into RyR1 cryo-EM maps, including a 13.6-Å resolution map for the closed state (EMDB entry code 5014, (10)), a 9.6-Å resolution map for the closed state (EMDB entry code 1275, (12)), and two 10.2-Å resolution maps for both closed and open conformations (EMDB entry codes 1606 and 1607, (11)). Laplacian filter and standard linear cross-correlation criteria were both applied.
Molecular dynamics flexible fitting into cryo-EM maps --We performed Molecular
Dynamics Flexible Fitting by using VMD (48) and NAMD (49), two program used for molecular visualization and molecular dynamics simulations, respectively. The top ranked solution for each monomer previously obtained by rigid-body docking was used as the initial structure. We segmented the corresponding volume where the docking model located from the overall homotetramer 3D reconstruction as the target map. To prevent over-fitting, we increased simulation steps gradually with varying energy minimization steps and inspected the cross-correlation coefficient (CCC) between each simulated map created from the MDFF trajectories and the segmented target map. The scaling factor was set to 1.0 for both the first 200 minimization steps, and the subsequent minimization steps. The CCC reached a plateau rapidly after thousands of simulated steps for models created by MODELLER or tens of thousands for models generated by I-TASSER server in both the closed and the open state maps (see parameter and results in Supplementary Table S1 ).
Secondary structural elements detection in RyR1 cryo-EM map --We used program
VolTrac from the Situs package (50) to predict the distribution of potential α-helices in regions of cryo-EM maps where we docked the modeled structures.
cDNA construction and FRET measurement --cDNAs encoding RyR2 Y846-CFP and RyR2 Y2801-YFP were constructed according to the previously described procedure (42, 51) . FRET measurements in the HEK293 cells co-expressing RyR2 Y846-CFP and RyR2 Y2801-YFP was performed as described previously (52) .
RESULTS

Homology detection and pseudo-atomic model generation --
The full-length rabbit RyR1 subunit consists of 5,037 amino acid residues (4), and the 3D architectures of RyR that have been determined by cryo-EM reveal that the native, homo-tetrameric RyR1 consists of a transmembrane region and a large cytoplasmic assembly which is composed of at least 15 structural domains (10) . Most of the solved crystal structures of RyR fragments are in the Nterminal region (13) (14) (15) (16) . The largest peptide fragment, consisting of first 559 residues, was docked in 3 structural domains in the center of cytoplasmic assembly (16) . Crystal structures of the phosphorylation domain in RyR1 (residues 2,733/2734-2,940), as well as the corresponding domains in RyR2 (residues 2,699-2,904) and in RyR3 (residues 2,597-2,800) were recently reported, and they were docked into a region near the corners of the square-shaped cytoplasmic assembly, also known as "clamp" structures (17, 18) .
We performed a protein alignment search of the Protein Data Bank for the rabbit RyR1 sequence starting from residue 533, rather than 559, since the last 27 residues of the crystallized fragment (1-559) are not visible in the electron density (16) . Multiple sequence alignments of this sequence in RyR1 using NCBI BLAST, I-TASSER, and Swiss Model Workspace protocols all found significant homology between sequence 850-1,056 in RyR1 with sequence 2,733-2,940 in RyR1, for which the X-ray-crystallographic structure is known (PDB entry code: 3RQR) (18) . Sequence identity between the two fragments ranged between 28.3% (Swiss Model) to 32.3% (NCBI BLAST and I-TASSER). We used ClustalW2 to align the corresponding sequence in mouse RyR2 (44) , as shown in Figure 1 . Pseudoatomic models were generated by alignment of RyR1 850-1,056 (or RyR2 861-1,067) with sequence 2,733-2,940, and using the crystal structure of fragment 2,733-2,940 as the template. Two separate modeling procedures were used: homology modeling using MODELLER (45) and ab initio modeling using the I-TASSER server (46) . Modeled structures generated from the two procedures are very similar and remain close to the available crystal structure (Figure 2 , Figure S1 , and Figure S2 ). They all have four α-helices linked by three loops and one loop each at the Nterminus and the C-terminus. The only substantial differences between the modeled structures and the template structure are in the loops and in the helix 3.
Docking pseudo-atomic models into cryo-EM maps --To determine the likely location of the RyR1 and RyR2 fragments in intact RyR, we first performed rigid-body docking using the Colores program from Situs package (47) . We used four cryo-EM maps of RyR1: a 13.6-Å resolution map for the closed state (EMDB entry code 5014, (10)), a 9.6-Å resolution map for closed state (EMDB entry code 1275, (12)), and two 10.2-Å resolution maps for both closed and open conformations (EMDB entry codes 1606 and 1607, (11)). The resolution of the available RyR2 cryo-EM maps is poorer than that of the best RyR1 maps, but RyR1 and RyR2 share a high degree of sequence identity (66%) (53) . Intact RyR1 and RyR2 structures determined by cryo-EM (7, 8) or fragment structures determined by X-ray crystallography (14) are also very similar to each other. We therefore estimated the location of RyR2 model by docking it into RyR1 cryo-EM maps.
It was suggested by Tung et al. that applying a Laplacian filter during the rigid-body docking was necessary for accuracy (16) . Application of a Laplacian filter while docking our two pseudo-atomic models localized them both to the central vestibule region of the cryo-EM maps of RyR1 closed state, even though credible evidence indicates that this region contains the first 559 amino acid residues (16) .
For the RyR1 open state cryo-EM map, the RyR1 fragment model docked in a region that contains both domains 5 and 9, while the RyR2 fragment model docked into domain 10, where the phosphorylation domain 2,733/2734-2,940 was previously docked ( Figure S3, (17,18) ). Using the standard linear cross-correlation fitting criterion instead of the Laplacian filter in the rigid-body docking localized both models to the region between domains 5 and 9 --the same docking position that was obtained for the RyR1 fragment in RyR1's open state conformation with the Laplacian filter applied. Given that there are four repeats, one in each subunit of the tetrameric structure, these were the 4 top ranked solutions in the open state cryo-EM maps, and solutions ranked 3 to 6 in the closed state maps (Figure 3) . Surprisingly, the top two solutions in the closed state did not show 4 repeats for the tetrameric RyR structure, but docked the models in two diagonally related subunits in a mirror orientation to the solutions ranked 3 -6, These two mirrored positions were similar to those for the phosphorylation domain in structural domain 10 described by Yuchi et al. (17) , as well as those we found for the crystal structure 3RQR in open conformation RyR1 map ( Figure S3 
Next, we docked the pseudo-atomic model for the RyR2 fragment into cryo-EM maps of RyR1. Interestingly, this pseudo-atomic model demonstrated a better fit, with the 4 top ranked solutions in both the closed and open states assuming the same location and orientation ( Figure S4 ). This location is the same as the top 4 solutions in the open state and solutions ranked 3 -6 in the closed state for the pseudo-atomic model of RyR1 residues 850-1,056. We favor this docking position since it is highly ranked for both RyR1 and RyR2 fragments, and it has the requisite 4-fold symmetry for the tetrameric RyR architecture. More importantly, the N-terminus (loop 1) of both models approaches the upper (cytoplasmic facing) surface of RyR1 in this position, which is consistent with our previous cryo-EM mapping of residue Tyr-846 in RyR2 (42) . The N-terminus of the models in other top ranked docking positions (ranked 5 or 6 for open state, or ranked 1, 2, 7, or 8 for closed state) all point to the bottom or interior, which does not agree with the cryo-EM location of Tyr-846. In addition, this docking position is adjacent to the FKBP12 binding site (22, 26) , which is consistent with our previous FRET characterization of two FRET pairs: one pair between RyR2-YFP (YFP inserted after residue Tyr-846) and CFP-FKBP12.6 (CFP fused to the N-terminus of FKBP12.6), and another pair between RyR2-GFP (GFP inserted after residue Tyr-846) and Alexa Fluor555-FKBP12.6 (labeled at residue Cys-14) (42) .
To obtain a better fit of the models into the cryo-EM maps, we used the Molecular Dynamics Flexible Fitting (MDFF) program (54, 55) implemented in NAMD (49) to perform flexible fitting of the rigid-body fitted pseudoatomic models. This program optimizes the fit of the pseudo-atomic models into the cryo-EM maps using restrained molecular dynamics simulations. The stereochemical properties and the secondary structure elements in the pseudo-atomic models are maintained through restraints, with the cryo-EM map as a guiding potential for model optimization in addition to the standard force field. Forces proportional to the gradient of the cryo-EM map are applied to drive atoms into highdensity regions of the map, resulting in a new structure that more closely conforms to the presumably native conformation of RyR captured by the cryo-EM data (54) . The resulting flexibly fitted pseudo-atomic models reveal slight changes compared to their initial rigid-body docked conformations ( Figure 4A ). The MDFF protocol was optimized to achieve the best crosscorrelation coefficient and to minimize overfitting (Supplemental Table S1 ). The crosscorrelation coefficients were improved from 0.67 to 0.70 by MDFF optimization for the RyR1 fragment, and from 0.66 to 0.70 for the RyR2 fragment, indicating slightly better fittings for both modeled fragments.
Since both of our models contain four characteristic α-helices, these should match densities resembling α-helices in the region of cryo-EM maps where the modeled structures are positioned. We used program VolTrac from the Situs package to trace α-helical densities in the cryo-EM map (50) . It predicted one helix (represented as a fine purple line in Figure 4B ), which matched helix 1, the longest α-helix in each model. Other rod-like densities, which could correspond to α-helices, are visually apparent in the cryo-EM maps and are also located where the other three α-helices are positioned in the modeled fragments. VolTrac presumably assigned low confidence scores to these densities because they appear discontinuous in the current intermediate resolution (~10Å) cryo-EM maps.
Interaction between modeled fragments and FKBP --In a previous study, Samso et al. determined the binding interface between FKBP12 and RyR1, and found a unique orientation for FKBP12 when fitted into a 16-Å resolution 3D cryo-EM map (26) . Two RyR1 cryo-EM maps used in the present study were reconstructed with bound FKBP12 (11) . Both pseudo-atomic models, that for RyR1 residues 850-1,056 and that for RyR2 residues 861-1,067, are docked adjacent to the FKBP binding site. To gain further insight on the interaction between RyR and FKBP, we docked the crystal structures of FKBP12 (PDB entry code: 2PPN) and FKBP12.6 (PDB entry code: 1C9H) into the 10.2-Å resolution RyR1 cryo-EM maps. The resulting docked model shows a direct interaction between the pseudo-atomic model for RyR1 residues 850-1,056 and FKBP12, and between the pseudoatomic model for RyR2 residues 861-1,067 and FKBP12.6, respectively ( Figure 5 and Figure S5 ).
Analysis of the interface between FKBP12 and the pseudo-atomic model for the RyR1 fragment reveals a high occurrence of charged residues. There are 6 negatively charged residues in FKBP12 (Glu-5, Glu-31, Asp-32, Asp-40, Asp-100 and Glu-102), which are all oriented towards RyR1. Correspondingly, there are 16 positively charged residues in RyR1, among which 9 residues are located in the interface that directly contacts FKBP12 ( Figure  5B ). These 9 residues (Lys-951, Lys-952, Arg-976, Arg-987, Arg-1025, Arg-1032, Arg-1033, Arg-1036, and Arg-1044) are located mainly in the C-terminal portion of loop 3, the N-terminal portion of helix 3, and the C-terminal portions of both loop 4 and helix 4. A total of 11 positively charged residues are either in loop 3 (Lys-945, Lys-951, Lys-952, Lys-954, Lys-957, Lys-966, and Arg-976) or in loop 4 (Arg-1016, Arg-1017, Arg-1020, and Arg-1025). Both loops are likely to be flexible and can probably adjust to interact more favorably with FKBP12. One noticeable residue in loop 3, Arg976, is less than 2Å away from the residue Asp32 in FKBP12, which suggests that they could participate in a salt bridge between RyR1 and FKBP12. Such complementary salt bridges could explain why FKBP12 is one of the strongest binding partners for RyR1 (32, 56) . Many charged residues are also clustered near the interface between the pseudoatomic model of RyR2 residues 861-1,067 and FKBP12.6. These include 17 positively charged residues in RyR2 and 4 negatively charged residues in FKBP12.6 ( Figure S5 ). However, there are no residue pairs close enough to form an obvious salt bridge connecting RyR2 and FKBP12.6. Thus, our two models suggest that electrostatic interactions may play an important role in FKBP binding to RyR.
Disease-causing mutations in the modeled structures --Multiple mutations in both
RyR1 and RyR2 have been identified and linked to skeletal myopathies and cardiovascular disease. Mutations in RyR1 are associated with malignant hyperthermia and central core disease (57) . In human skeletal muscles, the R1043C mutation in RyR1 causes malignant hyperthermia, a rare lifethreatening condition that is usually triggered by exposure to certain drugs used for general anesthesia (57) . Mutations in RyR2 are now linked to two genetic forms of cardiac arrhythmia: catecholaminergic polymorphic ventricular tachycardia and arrhythmogenic right ventricular cardiomyopathy (58) (59) (60) . Catecholaminergic polymorphic ventricular tachycardia is an autosomal dominant arrhythmic syndrome characterized by exercise induced polymorphic ventricular tachycardia, has been linked to two missense mutations in human cardiac muscle RyR2, R1013Q and R1051P (61, 62) .
Three of these disease-causing mutations are located in the sequence range of the modeled RyR1 and RyR2 fragments. These correspond to Ala-1002 (hRyR2 R1013), Cys-1040 (hRyR2 R1051), and Arg-1044 (hRyR1 R1043) in the rabbit RyR1 sequence. Their locations in the pseudo-atomic model for the RyR1 fragment are shown in Figure 6A . The corresponding locations of these residues (mouse RyR2 Arg-1013, Arg-1051, and Arg-1055) in the pseudo-atomic model for the docked RyR2 fragment are shown in Figure S6A . Both Cys-1040 and Arg-1044 in RyR1 (or Arg-1051 and Arg-1055 in RyR2) are located in helix 4 and could directly interact with FKBP. Future experiments are needed to determine whether these mutations alter the RyR binding affinity for FKBP, a mechanism that was previously proposed for RyR channel dysfunction (35, 36) . The third residue, Ala-1002 in RyR1 (or Arg-1013 in RyR2) is located in the C-terminal portion of helix 3. It is not close to the RyR/FKBP interface, but is in an interface with the phosphorylation domain (see result below).
Domain-domain interaction between the RyR fragment and the phosphorylation domain--
The crystal structure 3RQR, the template for our RyR1 and RyR2 fragment models, contains RyR1 residues 2,733-2,940 (18) . This fragment is highly enriched with serine residues, making it a hotspot for RyR phosphorylation by PKA or Ca 2+ /calmodulin-dependent protein kinase II (CaMKII). An independent study reported a crystal structure for an almost identical fragment (2,734-2,940, PDB entry code 4ERT) (17) . Both crystal structures have been docked into domain 10, in the corner of the clamp region in the RyR 3D cryo-EM map (17, 18) . Notably, domain 10 is next to the structural domains 9 and 5, where our RyR1 and RyR2 fragments were docked ( Figure  6B and Figure S6B ). This suggests the likelihood of a direct domain-domain interaction between the phosphorylation domain and the RyR1 or RyR2 fragments. The mutant residue, Ala-1002 in RyR1 (or Arg-1013 in RyR2) is located in the interface (see close-up view in Figure 6B and Figure S6B ). At least 11 disease-causing mutations were also found in the phosphorylation domain (RyR1 residues 2,733-2,940), among which 7 residues, E2764K, S2776F, S2776M, L2785V, T2787S, R2840W and S2843P, have a direct contact with the loop 4 in the RyR1 fragment model, which contains mutant residue Ala1002 (close-up view in Figure 6B ). In addition, the loop that contains mutations R2840W and S2843P is also termed a phosphorylation loop since it has multiple serines and threonines, which are the major phosphorylation targets for PKA and CaMKII (17) . In human RyR2, mutant residues S2808, T2810, S2811, S2814, T2820, and S2821, are all located in the phosphorylation loop, and directly contact the RyR2 fragment model (close-up view in Figure S6B ). Taken together, the mutations and residues that can be phosphorylated may alter the domain-domain interaction between the RyR fragments modeled and the phosphorylation domain, causing improper conformational changes that lead to RyR channel dysfunction (see Discussion section).
FRET characterization of dynamic domain-domain interaction --Based on the docking results, we hypothesize a direct interaction between the phosphorylation domain and the RyR1 and RyR2 fragment models. To test this hypothesis experimentally, we designed a FRET pair to assess the dynamics of such a domain-domain interaction. FRET is a biophysical technique to quantify dynamical behavior in molecules, such as protein-protein interactions, protein-DNA interactions, and protein conformational changes. To monitor conformational changes in a large protein complex such as RyR, one structural domain can be labeled with a donor and the other with an acceptor. The FRET signals can then be measured and used to identify interactions between the labeled structural domains. The efficiency of this energy transfer is inversely proportional to the sixth power of the distance between donor and acceptor making FRET extremely sensitive to small distance changes. Previously, we mapped a residue in the phosphorylation domain and a residue close to the N-terminus of the modeled structure in RyR2 by 3D cryo-EM with GFP inserted as a structural maker (42, 51) . In this study, we replaced the GFP that was inserted after Tyr-846 with a CFP, and replaced the GFP after Tyr-2801 with YFP. When the 2 cDNAs (RyR2 Y846-CFP and RyR2 Y2801-YFP ) are co-expressed in HEK293 cells, different hybrid tetrameric RyRs could be formed (see models in Figure 7A) . FRET pairs will be formed only when the following two criteria are both satisfied: (1) the donor (CFP) and acceptor (YFP) are within certain distance of each other (normally below 100Å); (2) the two domains containing CFP and YFP must belong to two neighboring RyR2 subunits. Models displayed in Figure 7A highlight FRET pairs formed only when the two domains form an inter-subunit interaction. No FRET will be detected in the case of an intra-subunit interaction. Based on our previous cryo-EM mappings, the CFP and YFP are close to each other (center-to-center distance is about 65Å), and according to a previous FRET study, the two domains likely belong to different RyR subunits (52) . FRET signals were detected in the HEK293 cells that co-expressed cDNAs of RyR2 Y846-CFP and RyR2 Y2801-YFP ( Figure 7B, 7C and 7D) . These FRET signals are also altered by caffeine, which is a RyR channel activator. Both these results provide an experimental support for our docked models. The conformational change also seems to be sensitive to the dose of caffeine, and can be reversed by removal of caffeine ( Figure 7D ). The decreases in FRET efficiency ( Figure 7C ) and in acceptor/donor emission ratio ( Figure 7D ) upon caffeine treatment indicate that the two structural domains separate from one another when the RyR channel switches from the closed to the open conformation.
DISCUSSION
Multiple sequences in RyR involved in FKBP binding --Marx et al. hypothesized that
PKA hyper-phosphorylates Ser-2808 in RyR2 (or Ser-2843 in RyR1), causing FKBP12.6 (FKBP12) dissociation from RyR2 (or RyR1), which directly enhances sarcoplasmic reticulum Ca 2+ leak and systolic dysfunction in heart failure (35, 36) . However, this proposed mechanism has been challenged by other laboratory findings, Li et al. did not find any effect of PKA phosphorylation of the RyR2 on calcium sparks in mouse ventricular myocytes (37). Jiang et al. did not observe dissociation of FKBP12.6 from RyR2 in cardiac microsomal membranes treated with PKA (38). Stange et al. (21) made site-directed substitutions of RyR1 at Ser-2843 and RyR2 at Ser-2809 (rabbit RyR2, corresponding to Ser-2808 in mouse), and showed that mutant RyR2s neither abolished FKBP12.6 binding nor substantially changed channel functional properties (39). Xiao et al. found that FKBP12.6 can bind to both the Ser-2808 phosphorylated and non-phosphorylated forms of RyR2, and that a S2808D phosphomimetic mutant retained the ability to bind FKBP12.6. Furthermore, complete phosphorylation at Ser-2808 by exogenous PKA did not disrupt the FKBP12.6-RyR2 complex (40) . Using 3D cryo-EM, we have mapped the phosphorylation site by GFP insertion and by antibody binding, and we found neither of these labels close to the FKBP binding site (51) . This structural evidence is further supported by the docked positions of crystal structures of the RyR phosphorylation domain (17, 18) , which suggest that Ser-2808 does not directly interact with FKBP. If phosphorylated Ser-2808 does cause a decrease in RyR's affinity for FKBP, it could do so through an indirect mechanism, such as through changes in interaction with the RyR1 or RyR2 fragments modeled in this study.
Besides Ser-2808, other motifs or sequences in RyR have been proposed to be important for FKBP binding, including the Val2461-Pro2462 motif in RyR1 (Ile2427-Pro2428 in RyR2) (33) , a region contained within the sequence 1,815-1,855 in RyR2 (41), and a Cterminal fragment spanning RyR2 residues 3,788-4,765 (63) . The FKBP12 and FKBP12.6 binding sites were mapped to the same position in the 3D structure of RyR1 and RyR2 by cryo-EM, and the position is at the junction of RyR structural domains 3, 5, and 9 (22, 25, 26) . These findings suggest that there could be more than one sequence in RyR that participates in FKBP binding, as multiple sequences may form a binding pocket for FKBP when RyR folds to its native structure and assembles into a homotetramer. In support of this hypothesis, we have mapped two residues in the 3D structure of RyR2, Tyr-846 and Thr-1874, and we found the structural domains bearing the two residues are both adjacent to the FKBP binding site (41, 42) . Here, our docking of the RyR1 and RyR2 fragment models into an RyR region comprising a portion of structural domain 5 and the upper portion of domain 9 is consistent with the 3D location of Tyr-846. Other FKBP binding motifs or sequences may fold into the lower portion of domain 9 and in domain 3, and all together form a binding pocket for FKBP.
Potential impact of certain RyR mutations on FKBP binding --Mutations in RyR2 in
patients with catecholaminergic polymorphic ventricular tachycardia reduce the binding affinity of FKBP12.6 for RyR2 and cause increased channel activity under conditions that simulate exercise, resulting in exercise-induced sudden cardiac death (64) . In this study, the RyR1 and RyR2 fragment models docked into RyR cryo-EM maps indicate a direct interaction with FKBP. Three disease-causing mutations have been identified in the region encompassed by the fragments, including two catecholaminergic polymorphic ventricular tachycardia mutations in human RyR2, and one malignant hyperthermia mutation in human RyR1. We have located their corresponding residues in the models; the catecholaminergic polymorphic ventricular tachycardia mutation R1051P and the malignant hyperthermia mutation R1043C are at the interface with FKBP. Intriguingly, both mutations convert a positively charge residue, arginine, to neutral residues, proline or cysteine. Also, in this work, we presented evidence that the interaction between RyR and FKBP is mainly electrostatic, which suggests that both of these mutations might reduce the binding affinity for FKBP through alterations in electrostatic interactions.
Certain mutations in RyR alter the interaction between RyR structural domains --
Another potential underlying mechanism for mutant RyR channel dysfunction involves abnormal domain-domain interactions (65) . According to this hypothesis, several RyR structural domains work in a coordinated manner to perform necessary conformational changes that control the Ca 2+ channel gating. An example of such a domain-domain interaction, for which many disruptive disease-causing mutations have been discovered, involves an N-terminal region and a sequence from the central region of RyR's sequence. Several lines of experimental evidence support the hypothesis that mutations in either domain weaken the normal inter-domain interaction, and lead to enhance RyR Ca 2+ channel opening (66) (67) (68) . Recently, some disease-causing mutations were mapped in the crystal structure of the RyR1 fragment containing the first 559 residues, which include 33 mutations in RyR1 and 23 mutations in RyR2 (positions in RyR1 that correspond to mutated residues in RyR2). Among them, only 6 mutations (3 in RyR1 and 3 in RyR2) are buried within a folding domain, and the other 50 mutations all distribute at domaindomain interfaces either between the N-terminal ABC domains or between ABC domains and other neighboring domains (16) . One notable interface occurs between domains A and B across two subunits (an inter-subunit interaction), with 19 mutations clustering at this interface, suggesting an inter-subunit contact plays an important role in RyR function (16). Ikemoto's hypothesized domain-domain interaction that involves N-terminal and central mutation domains has also been identified as an inter-subunit interaction (52) . In this work, the domain-domain interaction between the RyR fragment models and the phosphorylation domain is also characterized as an inter-subunit interaction. Similar to many potassium channels, a functional RyR is a homotetramer that is composed of four identical subunits that are arranged symmetrically around the pore. In the KcsA potassium channel, there is evidence to suggest that direct interaction between the four subunits leads to a cooperative opening and closing of the ion-conducting pore (69) , which is structurally similar to the pore region of RyR (10, 11) . Here, we have identified a third inter-subunit domain-domain pair involving two structurally homologous domains derived from amino acid residues 850-1,056 in one subunit and 2,733-2,940 in an adjacent subunit. Based on the present results and previous studies, we suggest that mutations in either domain may weaken the normal subunit-subunit interactions, thus altering the stability of the RyR channel. A Protein BLAST alignment of rabbit RyR1 and mouse RyR2 sequences against the sequences for all structures deposited in the Protein Data Bank (PDB) was performed. The result shows that one portion of RyR1, residues 850-1,056 (or for RyR2, 861-1,067) has been aligned with the sequence of 3RQR chain A (a crystal structure of a fragment of rabbit RyR1, residues 2,733-2,940) with a highly statistically significant alignment score. Sequence identity between 850-1,056 and 2,733-2,940 is 32.3%. Corresponding secondary structural elements are indicated above the sequences. α-helices are indicated by coils and β-strands by arrows. Regions with identical amino acids are highlighted in dark red and similar residues in light red. Pseudo-atomic models of rabbit RyR1 fragment (residues 850-1,056) (B) and mouse RyR2 fragment (residues 861-1,067) (C) generated by homology modeling based on the template crystal structure 3RQR (A) using the program MODELLER. The sequence order shown in the figure is as follows: N-terminus, loop 1, helix 1 (blue), loop 2, helix 2 (green), loop 3, helix 3 (yellow), loop 4, helix 4 (red), loop 5, Cterminus. by guest on November 19, 2017 
